In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cellsMarion T. Weigel(Christian-Albrechts-Universität zu Kiel), Christoph Mundhenke(Bayreuth Medical Center)BMC CancerAugust 9, 201010.1186/1471-2407-10-412Cited by 56SaveCiteExport RISWatch citationsRelated PapersPreclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer|Breast Cancer Research|2012|43